iNtRON Biotechnology Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	27,664	34,359	40,987	25,811	75,170
Short-Term Investments	295.81	1,832	52.88	61,137	30,000
Trading Asset Securities	13,816	13,652	16,144	21,403	8,327
Cash & Short-Term Investments	41,775	49,843	57,184	108,351	113,497
Cash Growth	-16.19%	-12.84%	-47.22%	-4.53%	71.53%
Accounts Receivable	817.07	912.97	1,988	3,778	9,754
Other Receivables	150.96	44.25	660.26	471.4	851.74
Receivables	968.02	966.04	2,697	4,250	10,641
Inventory	841.93	1,124	1,011	800.39	1,002
Prepaid Expenses	-	-	-	36.69	69.19
Other Current Assets	229.65	292.81	87.89	490.14	303.53
Total Current Assets	43,815	52,226	60,980	113,928	125,513
Property, Plant & Equipment	20,602	19,740	22,696	15,031	13,758
Long-Term Investments	7,921	12,185	12,496	9,514	10,592
Other Intangible Assets	1,039	1,373	1,405	1,386	1,213
Long-Term Accounts Receivable	0	0	0	-	-
Long-Term Deferred Tax Assets	-	-	-	-	1,153
Other Long-Term Assets	944.02	850.33	1,038	1,070	1,136
Total Assets	74,322	86,375	98,615	140,959	153,365
Accounts Payable	-	-	0.42	97	561.02
Accrued Expenses	5.71	-	-	5.34	2.38
Short-Term Debt	3,000	-	-	30,810	29,494
Current Portion of Leases	133.96	168.48	144.62	174.98	132.88
Current Income Taxes Payable	-	-	-	-	1,267
Other Current Liabilities	946.21	1,170	640.94	1,130	1,796
Total Current Liabilities	4,086	1,338	785.97	32,218	33,254
Long-Term Debt	-	861.44	-	-	16,067
Long-Term Leases	219.77	214.72	258.3	286.37	61.62
Pension & Post-Retirement Benefits	-	-	615.76	200.48	322.23
Long-Term Deferred Tax Liabilities	-	74.99	83.99	1,565	-
Other Long-Term Liabilities	142.7	112.7	136.35	508.05	2,312
Total Liabilities	4,448	2,602	1,880	34,777	52,016
Common Stock	17,075	17,075	17,075	17,075	16,898
Additional Paid-In Capital	40,978	40,978	40,978	80,978	73,604
Retained Earnings	23,100	42,770	48,680	18,549	12,733
Treasury Stock	-12,357	-18,146	-10,960	-10,960	-1,967
Comprehensive Income & Other	1,077	1,095	960.68	538.31	81.52
Total Common Equity	69,873	83,773	96,734	106,181	101,349
Shareholders' Equity	69,873	83,773	96,734	106,181	101,349
Total Liabilities & Equity	74,322	86,375	98,615	140,959	153,365
Total Debt	3,354	1,245	402.91	31,271	45,756
Net Cash (Debt)	38,422	48,598	56,781	77,080	67,741
Net Cash Growth	-20.94%	-14.41%	-26.33%	13.79%	21.22%
Net Cash Per Share	1213.75	1481.68	1710.73	2272.18	2008.38
Filing Date Shares Outstanding	31.59	31.98	33.19	33.19	33.73
Total Common Shares Outstanding	31.59	31.98	33.19	33.19	33.73
Working Capital	39,729	50,888	60,194	81,710	92,259
Book Value Per Share	2211.97	2619.70	2914.42	3199.04	3004.79
Tangible Book Value	68,834	82,400	95,329	104,796	100,137
Tangible Book Value Per Share	2179.07	2576.77	2872.08	3157.30	2968.84
Land	4,318	3,659	4,072	2,631	2,631
Buildings	15,808	13,172	13,567	7,269	7,488
Machinery	4,764	4,757	1,826	2,382	1,235
Construction In Progress	-	1,119	-	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.